secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-03-29T23:59:59+00:00
Accession:  0001493152-24-011871
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences receives Nasdaq deficiency notice for bid price below $1.00, given 180 days to comply
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on March 27, 2024 for bid price closing below $1.00 for 30 consecutive business days.
- Has until September 23, 2024 to regain compliance by maintaining $1.00 bid price for at least 10 consecutive business days.
- Also has prior stockholders' equity non-compliance; Nasdaq Panel granted continued listing until May 13, 2024.
- Company will monitor closing bid price and evaluate options, but no assurance of regaining or maintaining compliance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224011871/0001493152-24-011871-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224011871/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-011871

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer